Precision medicine and personalized breast cancer: combination pertuzumab therapy

Precision medicine and personalized breast cancer: combination pertuzumab therapy

Kerry Reynolds, Sasmit Sarangi, Aditya Bardia, Don S Dizon Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA Abstract: Trastuzumab (Herceptin), a monoclonal antibody directed against the human epidermal growth-factor receptor 2 (HER2), is the poster child for an...

Full description

Bibliographic Details
Main Authors: Reynolds K, Sarangi S, Bardia A, Dizon DS
Format: Article
Language:English
Published: Dove Medical Press 2014-03-01
Series:Pharmacogenomics and Personalized Medicine
Online Access:http://www.dovepress.com/precision-medicine-and-personalized-breast-cancer-combination-pertuzum-a16169

Similar Items

Similar Items